ICH ICH Enumeration: ShortName=ICH M11 Section 4 Terminology

M2 ESTRI Code List

ShortName = ICH M11 Section 4 Terminology
LongName = ICH M11 Section 4 Terminology
Version = 1.0
CanonicalUri = 2.16.840.1.113883.3.989.2.3.3.4
CanonicalVersionUri = 2.16.840.1.113883.3.989.2.3.3.4.1
Agency
ShortName = M11
LongName = Clinical Trial protocols
Identifier = C217345
code
Id="code"
(required)
Type="string"
english-label
Id="en"
(optional)
Type="string" Lang="en"
M11 Definition
Id="en_def"
(optional)
Type="string" Lang="en"
current flag
Id="cf"
(optional)
Type="string" Lang="en"
C218738 Access to Trial Intervention After End of Trial A narrative description containing information about whether and how trial participants have access to the trial interventions after the trial ends. y
C218728 Additional Description of Trial Design An extra or further textual description of the trial design. y
C218727 Description of Level and Method of Blinding A description of the level of awareness of the study participants and/or personnel to the respective intervention(s) or assessments being observed, received or administered, and the methodology by which study participants or personnel are blinded. y
C219658 Description of Method of Assignment to Trial Intervention A description of the methodology used to assign trial participants to a trial intervention or trial arm. y
C218726 Description of Trial Duration A description of the trial duration. y
C218737 End of Trial A description containing a concise explanation, any local regulatory requirements and considerations, extensions, follow-up, and analysis for the trial end. y
C147139 Overall Description of Trial Design and Description of Intervention Model A description summarizing the overall trial design and intervention model. y
C142705 Overall Rationale for Trial Design An explanation as to the scientific reasons for the choice of the trial design. y
C218733 Rationale for Adaptive or Novel Trial Design An explanation as to the scientific reasons for why an adaptive or novel trial design was chosen for the trial. y
C218731 Rationale for Control Type An explanation as to the scientific reasons for the choice of the control types used in the trial. y
C218730 Rationale for Estimand(s) An explanation as to the scientific reasons for the choice of the trial estimand(s). y
C218734 Rationale for Interim Analysis An explanation for the analysis comparing intervention groups at any time before the formal completion of the trial, usually before recruitment is complete. y
C215629 Rationale for Intervention Model An explanation as to the scientific reasons for why the intervention model was chosen for the trial. y
C218735 Rationale for Other Trial Design Aspects An explanation as to the scientific reasons for additional trial design considerations that are different than the one(s) previously specified or mentioned. y
C218732 Rationale for Trial Duration An explanation as to the scientific reasons for the trial duration. y
C218729 Stakeholder Input into Design A description of the way in which trial stakeholders were consulted when determining the trial design and how that input was applied. y
C218736 Start of Trial A description containing a concise explanation, any local regulatory requirements and considerations, extensions, follow-up, and analysis for the trial start. y
C142698 Trial Stopping Rules A criterion that, when met by the accumulating data, indicates that the trial can or should be stopped early to avoid putting participants at risk unnecessarily or because the intervention effect is so great that further data collection is unnecessary. y

This file contains a code list co-maintained by ICH M2 ESTRI and CDISC in collaboration with the NCI Enterprise Vocabulary Services (EVS). It is encoded using OASIS genericode. More information on ICH technical standards is available via the M2 ESTRI webpages at www.ich.org.

Change History: v1.0 (November 11 2025)

Report created by ICH_M2_CDISC_Codelist.xsl : [Revision: 1.1 ] : ICH : Harmonisation for Better Health